Kyoto Pharmaceutical Industries

Kyoto, Japan· Est. 1946

Japanese pharmaceutical company developing innovative small molecule drugs for cardiovascular and metabolic diseases through novel compound discovery and proprietary formulations.

kyoto-pharm.co.jp

Is this your company? Claim your profile to update info and connect with investors.

Claim profile

Private Company

Funding information not available

AI Company Overview

Japanese pharmaceutical company developing innovative small molecule drugs for cardiovascular and metabolic diseases through novel compound discovery and proprietary formulations.

CardiovascularMetabolic

Technology Platform

Small molecule drug discovery with focus on novel compound identification and development of proprietary formulations for innovative drugs.

Opportunities

Opportunities include leveraging their 80-year history and formulation expertise to develop innovative cardiovascular and metabolic drugs, and expanding their contract manufacturing operations.

Risk Factors

Key risks include competition from larger pharmaceutical companies, reliance on successful R&D outcomes for future growth, and challenges in advancing novel compounds through clinical development.

Competitive Landscape

Competes with other Japanese pharmaceutical companies in cardiovascular and metabolic spaces; differentiates through formulation expertise, manufacturing quality, and venture-spirit approach despite long history.

More companies in Japan →